CN Patent

CN104744445A — 一种酪氨酸激酶抑制剂的晶型

Assigned to Sunshine Lake Pharma Co Ltd · Expires 2015-07-01 · 11y expired

What this patent protects

本发明一种酪氨酸激酶抑制剂的晶型，涉及一种可用于治疗非小细胞肺癌的药物阿法替尼二马来酸盐的新晶型、其制备方法、药物组合物等，所述新晶型的X-射线粉末衍射图中在2θ为5.45度的位置有峰，其相对强度大于90％；并且所述晶型具有较好的流动相和低吸湿性等理化性质，可用于药物制剂。

USPTO Abstract

本发明一种酪氨酸激酶抑制剂的晶型，涉及一种可用于治疗非小细胞肺癌的药物阿法替尼二马来酸盐的新晶型、其制备方法、药物组合物等，所述新晶型的X-射线粉末衍射图中在2θ为5.45度的位置有峰，其相对强度大于90％；并且所述晶型具有较好的流动相和低吸湿性等理化性质，可用于药物制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN104744445A
Jurisdiction
CN
Classification
—
Expires
2015-07-01
Drug substance claim
No
Drug product claim
No
Assignee
Sunshine Lake Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.